医学
诱导疗法
内科学
克罗恩病
维持疗法
疾病
化疗
作者
Edward V. Loftus,Julián Panés,Ana P. Lacerda,Laurent Peyrin‐Biroulet,Geert D’Haens,Remo Panaccione,Walter Reinisch,Édouard Louis,Minhu Chen,Hiroshi Nakase,Jakob Begun,Brigid S. Boland,Charles D. Phillips,Mohamed‐Eslam F. Mohamed,Jianzhong Liu,Ziqian Geng,Feng Tian,Elena Dubcenco,Jean‐Frédéric Colombel
标识
DOI：10.1056/nejmoa2212728
摘要
Upadacitinib induction and maintenance treatment was superior to placebo in patients with moderate-to-severe Crohn's disease. (Funded by AbbVie; U-EXCEL, U-EXCEED, and U-ENDURE ClinicalTrials.gov numbers, NCT03345849, NCT03345836, and NCT03345823.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
热心市民小杨
橘x
从容水蓝
nino
互助
yyds
无奈的碧彤
tiptip
GingerF
干净的琦
felyne
JIA
彭于彦祖
核桃
andrele
penxyy
Wind
大力的灵雁
tuanheqi
愔愔
皖公网安备34019202002308
